A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in ...

The findings of trials using intismeran, an mRNA-based individualised vaccine, was published at the 2026 annual meeting of ...

Dried mRNA vaccines can match standard injection without cold storage when a polymer matrix at the right ratio prevents the structural failures that destroy lipid nanoparticles during drying.

Individualized vaccines are built from resected tumor, using analytics to prioritize neoantigens most likely to be immunogenic, then encoding these targets into an mRNA construct tailored to each ...

There is an effective vaccine for Ebola — but not for the variety spreading rapidly in the Democratic Republic of Congo.

Tests with rodents suggest an mRNA vaccine in development offers protection against three strains of Ebola virus, including the one behind the current crisis ...

It is finally bouncing back after several challenging years.

Since 2023, Moderna and Korea University have been developing a new mRNA vaccine for hantavirus. The work has been promising so far, but a finished product isn't likely coming any time soon.

New medicines are getting better. But so is our ability to get them where they need to go.

The virus species now fueling the Ebola outbreak in Africa has no specific vaccines or drugs yet to fight it. Scientists are ...